Thomas Schroeppel
Concepts (436)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 38 | 2026 | 959 | 5.820 |
Why?
| | Trauma Centers | 44 | 2026 | 441 | 4.540 |
Why?
| | Injury Severity Score | 46 | 2026 | 572 | 3.280 |
Why?
| | Wounds, Nonpenetrating | 17 | 2026 | 305 | 2.840 |
Why?
| | Brain Injuries | 9 | 2023 | 499 | 2.780 |
Why?
| | Rib Fractures | 4 | 2024 | 34 | 2.580 |
Why?
| | Brain Injuries, Traumatic | 11 | 2026 | 466 | 2.100 |
Why?
| | Chest Tubes | 4 | 2025 | 32 | 1.910 |
Why?
| | Retrospective Studies | 76 | 2026 | 17438 | 1.880 |
Why?
| | Abdominal Injuries | 12 | 2026 | 122 | 1.870 |
Why?
| | Practice Guidelines as Topic | 8 | 2026 | 1591 | 1.860 |
Why?
| | Length of Stay | 23 | 2026 | 1358 | 1.690 |
Why?
| | Venous Thromboembolism | 5 | 2025 | 332 | 1.570 |
Why?
| | Glasgow Coma Scale | 15 | 2026 | 211 | 1.470 |
Why?
| | Hospital Mortality | 15 | 2024 | 1051 | 1.460 |
Why?
| | Triage | 7 | 2025 | 243 | 1.440 |
Why?
| | Anticoagulants | 10 | 2025 | 746 | 1.420 |
Why?
| | Trauma Severity Indices | 6 | 2022 | 115 | 1.370 |
Why?
| | Thoracic Injuries | 6 | 2024 | 69 | 1.360 |
Why?
| | Intracranial Hemorrhage, Traumatic | 2 | 2020 | 11 | 1.260 |
Why?
| | Adrenergic beta-Antagonists | 5 | 2018 | 253 | 1.250 |
Why?
| | Tomography, X-Ray Computed | 14 | 2026 | 2786 | 1.220 |
Why?
| | Adult | 88 | 2026 | 41087 | 1.220 |
Why?
| | Wounds, Penetrating | 7 | 2026 | 71 | 1.120 |
Why?
| | General Surgery | 7 | 2022 | 217 | 1.080 |
Why?
| | Hemothorax | 4 | 2024 | 19 | 1.050 |
Why?
| | Intracranial Hemorrhages | 2 | 2026 | 106 | 1.050 |
Why?
| | Humans | 137 | 2026 | 146342 | 1.000 |
Why?
| | Middle Aged | 72 | 2026 | 36619 | 1.000 |
Why?
| | Thoracostomy | 2 | 2024 | 26 | 0.990 |
Why?
| | Female | 106 | 2026 | 79499 | 0.980 |
Why?
| | Embolization, Therapeutic | 6 | 2025 | 246 | 0.980 |
Why?
| | Warfarin | 4 | 2024 | 179 | 0.970 |
Why?
| | Male | 103 | 2026 | 73396 | 0.970 |
Why?
| | Appendicitis | 3 | 2020 | 151 | 0.920 |
Why?
| | Radiography, Thoracic | 3 | 2025 | 174 | 0.910 |
Why?
| | Cholecystitis, Acute | 5 | 2024 | 26 | 0.900 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 5 | 0.850 |
Why?
| | Aged | 51 | 2025 | 26432 | 0.850 |
Why?
| | Primary Dysautonomias | 2 | 2014 | 4 | 0.830 |
Why?
| | Stroke | 4 | 2023 | 1287 | 0.820 |
Why?
| | Pneumothorax | 2 | 2024 | 54 | 0.820 |
Why?
| | Propranolol | 2 | 2014 | 44 | 0.820 |
Why?
| | Device Removal | 1 | 2025 | 149 | 0.810 |
Why?
| | Frailty | 2 | 2024 | 208 | 0.780 |
Why?
| | Vital Capacity | 2 | 2021 | 293 | 0.770 |
Why?
| | Postpartum Hemorrhage | 1 | 2023 | 28 | 0.760 |
Why?
| | Contusions | 1 | 2023 | 25 | 0.760 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2024 | 499 | 0.740 |
Why?
| | Telemetry | 1 | 2022 | 41 | 0.720 |
Why?
| | Intensive Care Units | 12 | 2021 | 925 | 0.710 |
Why?
| | Syncope | 1 | 2022 | 48 | 0.710 |
Why?
| | Time-to-Treatment | 2 | 2021 | 257 | 0.710 |
Why?
| | Resuscitation | 7 | 2024 | 314 | 0.690 |
Why?
| | Critical Care | 5 | 2023 | 706 | 0.680 |
Why?
| | Decompressive Craniectomy | 2 | 2018 | 9 | 0.680 |
Why?
| | Transfusion Reaction | 1 | 2021 | 61 | 0.680 |
Why?
| | Laparotomy | 7 | 2023 | 111 | 0.660 |
Why?
| | Advance Directives | 1 | 2022 | 89 | 0.650 |
Why?
| | Hospitalization | 7 | 2023 | 2475 | 0.650 |
Why?
| | Appendix | 2 | 2018 | 31 | 0.640 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 245 | 0.620 |
Why?
| | Hemorrhage | 7 | 2025 | 825 | 0.620 |
Why?
| | Prospective Studies | 33 | 2026 | 8123 | 0.600 |
Why?
| | Craniocerebral Trauma | 1 | 2022 | 173 | 0.600 |
Why?
| | Recovery of Function | 4 | 2020 | 725 | 0.600 |
Why?
| | Surgeons | 2 | 2023 | 351 | 0.590 |
Why?
| | Blood Transfusion | 7 | 2023 | 394 | 0.580 |
Why?
| | Patient Admission | 1 | 2021 | 216 | 0.570 |
Why?
| | Cholecystectomy, Laparoscopic | 3 | 2023 | 59 | 0.570 |
Why?
| | Laparoscopy | 5 | 2022 | 487 | 0.560 |
Why?
| | Propofol Infusion Syndrome | 1 | 2018 | 1 | 0.560 |
Why?
| | Duodenum | 2 | 2016 | 76 | 0.560 |
Why?
| | Choledocholithiasis | 3 | 2019 | 20 | 0.540 |
Why?
| | Internship and Residency | 3 | 2015 | 1281 | 0.540 |
Why?
| | Emergency Medical Services | 7 | 2025 | 680 | 0.530 |
Why?
| | Blood Component Transfusion | 4 | 2024 | 99 | 0.520 |
Why?
| | Disease Management | 3 | 2018 | 651 | 0.510 |
Why?
| | Liver | 7 | 2024 | 1864 | 0.500 |
Why?
| | Head Injuries, Closed | 3 | 2016 | 49 | 0.500 |
Why?
| | Treatment Outcome | 31 | 2025 | 11821 | 0.500 |
Why?
| | Wounds, Gunshot | 6 | 2023 | 262 | 0.500 |
Why?
| | Workload | 3 | 2020 | 170 | 0.490 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 365 | 0.490 |
Why?
| | Electronic Health Records | 1 | 2025 | 1210 | 0.480 |
Why?
| | Risk Assessment | 14 | 2025 | 3712 | 0.460 |
Why?
| | United States | 28 | 2026 | 16136 | 0.460 |
Why?
| | Pneumonia, Ventilator-Associated | 5 | 2015 | 58 | 0.450 |
Why?
| | Sutures | 1 | 2016 | 66 | 0.450 |
Why?
| | Critical Illness | 6 | 2026 | 908 | 0.450 |
Why?
| | Cervical Vertebrae | 3 | 2026 | 170 | 0.440 |
Why?
| | Suture Techniques | 1 | 2016 | 138 | 0.430 |
Why?
| | Cholecystectomy | 4 | 2024 | 63 | 0.420 |
Why?
| | Colon | 3 | 2026 | 304 | 0.420 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 144 | 0.410 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 560 | 0.410 |
Why?
| | Forecasting | 1 | 2016 | 388 | 0.410 |
Why?
| | Survival Rate | 7 | 2021 | 2092 | 0.410 |
Why?
| | Prognosis | 9 | 2022 | 4351 | 0.390 |
Why?
| | Tourniquets | 2 | 2025 | 34 | 0.390 |
Why?
| | Emergencies | 4 | 2024 | 177 | 0.390 |
Why?
| | Nursing Assessment | 1 | 2013 | 53 | 0.380 |
Why?
| | Logistic Models | 10 | 2024 | 2126 | 0.380 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 67 | 0.380 |
Why?
| | Geriatric Assessment | 3 | 2024 | 244 | 0.370 |
Why?
| | Cholecystitis | 2 | 2023 | 25 | 0.370 |
Why?
| | Young Adult | 19 | 2025 | 14330 | 0.370 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2021 | 218 | 0.370 |
Why?
| | Time Factors | 8 | 2025 | 7109 | 0.370 |
Why?
| | Tennessee | 5 | 2016 | 57 | 0.360 |
Why?
| | Propofol | 1 | 2013 | 86 | 0.360 |
Why?
| | Colectomy | 2 | 2025 | 119 | 0.360 |
Why?
| | Erythrocyte Transfusion | 4 | 2024 | 226 | 0.360 |
Why?
| | Brain Concussion | 1 | 2020 | 660 | 0.360 |
Why?
| | Aged, 80 and over | 15 | 2025 | 8391 | 0.350 |
Why?
| | Surgical Wound Infection | 3 | 2026 | 349 | 0.350 |
Why?
| | Severity of Illness Index | 6 | 2024 | 2921 | 0.330 |
Why?
| | Nutritional Support | 2 | 2026 | 39 | 0.330 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1942 | 0.330 |
Why?
| | Emergency Service, Hospital | 7 | 2023 | 2363 | 0.310 |
Why?
| | Clinical Protocols | 3 | 2026 | 282 | 0.310 |
Why?
| | Anastomosis, Surgical | 5 | 2026 | 164 | 0.300 |
Why?
| | Neuroprotective Agents | 1 | 2010 | 146 | 0.290 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 303 | 0.290 |
Why?
| | Firearms | 4 | 2025 | 444 | 0.290 |
Why?
| | Carbon Dioxide | 2 | 2022 | 228 | 0.290 |
Why?
| | Fractures, Bone | 2 | 2025 | 436 | 0.290 |
Why?
| | Respiration, Artificial | 3 | 2022 | 711 | 0.280 |
Why?
| | Emergency Treatment | 2 | 2020 | 122 | 0.280 |
Why?
| | Follow-Up Studies | 8 | 2020 | 5439 | 0.280 |
Why?
| | Algorithms | 4 | 2021 | 1849 | 0.280 |
Why?
| | Postoperative Complications | 9 | 2025 | 3034 | 0.280 |
Why?
| | Quality Improvement | 1 | 2017 | 1354 | 0.270 |
Why?
| | Medical Errors | 1 | 2009 | 124 | 0.270 |
Why?
| | Spinal Injuries | 2 | 2026 | 62 | 0.260 |
Why?
| | Cohort Studies | 8 | 2023 | 6077 | 0.250 |
Why?
| | Hospital Charges | 1 | 2007 | 45 | 0.250 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1408 | 0.250 |
Why?
| | Hepatic Artery | 2 | 2024 | 53 | 0.250 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 2113 | 0.240 |
Why?
| | Seasons | 1 | 2009 | 540 | 0.240 |
Why?
| | Risk Factors | 9 | 2025 | 10921 | 0.240 |
Why?
| | Pregnancy, Tubal | 1 | 2006 | 5 | 0.240 |
Why?
| | Hemoperitoneum | 1 | 2006 | 10 | 0.240 |
Why?
| | Abdomen, Acute | 1 | 2006 | 20 | 0.240 |
Why?
| | Regression Analysis | 3 | 2021 | 999 | 0.240 |
Why?
| | Advanced Trauma Life Support Care | 1 | 2026 | 4 | 0.230 |
Why?
| | Fallopian Tubes | 1 | 2006 | 33 | 0.230 |
Why?
| | Frail Elderly | 2 | 2024 | 141 | 0.230 |
Why?
| | Appendectomy | 2 | 2020 | 93 | 0.230 |
Why?
| | Colorado | 5 | 2022 | 4595 | 0.230 |
Why?
| | Adolescent | 22 | 2026 | 22557 | 0.220 |
Why?
| | Malnutrition | 1 | 2026 | 87 | 0.220 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2005 | 23 | 0.220 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2025 | 37 | 0.220 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2005 | 8 | 0.220 |
Why?
| | Shock, Hemorrhagic | 2 | 2019 | 195 | 0.210 |
Why?
| | Administration, Oral | 3 | 2024 | 872 | 0.210 |
Why?
| | Plasma | 2 | 2024 | 222 | 0.210 |
Why?
| | Pelvis | 1 | 2025 | 129 | 0.210 |
Why?
| | Multivariate Analysis | 6 | 2020 | 1543 | 0.210 |
Why?
| | Registries | 7 | 2021 | 2400 | 0.210 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2024 | 20 | 0.200 |
Why?
| | Abdominal Cavity | 1 | 2023 | 5 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 2022 | 0.200 |
Why?
| | Incidence | 9 | 2020 | 2936 | 0.200 |
Why?
| | Linear Models | 2 | 2021 | 857 | 0.200 |
Why?
| | Patient Readmission | 2 | 2020 | 778 | 0.200 |
Why?
| | Abdominal Abscess | 1 | 2023 | 28 | 0.200 |
Why?
| | Abdomen | 4 | 2023 | 142 | 0.200 |
Why?
| | Pelvic Bones | 1 | 2025 | 137 | 0.190 |
Why?
| | Gastric Bypass | 1 | 2005 | 115 | 0.190 |
Why?
| | Analgesics, Opioid | 2 | 2024 | 1221 | 0.190 |
Why?
| | Treatment Failure | 1 | 2024 | 361 | 0.190 |
Why?
| | Leg Injuries | 1 | 2023 | 25 | 0.190 |
Why?
| | Spleen | 3 | 2012 | 503 | 0.190 |
Why?
| | Patient Discharge | 5 | 2025 | 997 | 0.190 |
Why?
| | Venous Thrombosis | 1 | 2025 | 199 | 0.190 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2023 | 61 | 0.190 |
Why?
| | Cerebrovascular Trauma | 1 | 2023 | 22 | 0.180 |
Why?
| | Equipment Design | 1 | 2024 | 520 | 0.180 |
Why?
| | Tibial Fractures | 1 | 2023 | 77 | 0.180 |
Why?
| | Blood Coagulation | 2 | 2023 | 267 | 0.180 |
Why?
| | Factor Xa Inhibitors | 2 | 2022 | 195 | 0.180 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 24 | 0.180 |
Why?
| | Intraabdominal Infections | 1 | 2022 | 12 | 0.180 |
Why?
| | Ischemia | 1 | 2025 | 421 | 0.180 |
Why?
| | Surgical Procedures, Operative | 2 | 2024 | 307 | 0.180 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2022 | 15 | 0.180 |
Why?
| | Pregnancy | 2 | 2023 | 7230 | 0.170 |
Why?
| | Diagnostic Tests, Routine | 1 | 2022 | 109 | 0.170 |
Why?
| | Comorbidity | 3 | 2022 | 1665 | 0.170 |
Why?
| | Thrombolytic Therapy | 1 | 2022 | 165 | 0.160 |
Why?
| | Enoxaparin | 1 | 2021 | 68 | 0.160 |
Why?
| | Platelet Transfusion | 1 | 2022 | 76 | 0.160 |
Why?
| | Extremities | 1 | 2022 | 142 | 0.160 |
Why?
| | Coagulants | 1 | 2021 | 20 | 0.160 |
Why?
| | Diverticulitis, Colonic | 1 | 2020 | 11 | 0.160 |
Why?
| | Enteral Nutrition | 3 | 2026 | 212 | 0.160 |
Why?
| | Pneumonia, Bacterial | 2 | 2015 | 114 | 0.160 |
Why?
| | Obesity, Morbid | 1 | 2005 | 287 | 0.160 |
Why?
| | Resource Allocation | 1 | 2021 | 45 | 0.160 |
Why?
| | Wilderness | 1 | 2020 | 12 | 0.160 |
Why?
| | Altitude | 1 | 2025 | 469 | 0.160 |
Why?
| | Colorectal Surgery | 1 | 2020 | 32 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2026 | 568 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2025 | 594 | 0.160 |
Why?
| | Mountaineering | 1 | 2020 | 35 | 0.160 |
Why?
| | Accidental Falls | 2 | 2020 | 227 | 0.160 |
Why?
| | Omentum | 1 | 2019 | 9 | 0.150 |
Why?
| | Peptic Ulcer Perforation | 1 | 2019 | 4 | 0.150 |
Why?
| | Physician's Role | 1 | 2022 | 225 | 0.150 |
Why?
| | Prisoners | 1 | 2022 | 146 | 0.150 |
Why?
| | Hypoventilation | 1 | 2019 | 17 | 0.150 |
Why?
| | Head Injuries, Penetrating | 1 | 2019 | 5 | 0.150 |
Why?
| | Suicidal Ideation | 1 | 2025 | 543 | 0.150 |
Why?
| | Skin Diseases, Infectious | 1 | 2019 | 14 | 0.150 |
Why?
| | Drug Utilization | 1 | 2020 | 171 | 0.150 |
Why?
| | Cross Infection | 2 | 2015 | 258 | 0.150 |
Why?
| | Patient Care Team | 1 | 2025 | 701 | 0.140 |
Why?
| | Echocardiography | 1 | 2022 | 645 | 0.140 |
Why?
| | Reproducibility of Results | 4 | 2022 | 3416 | 0.140 |
Why?
| | Age Factors | 4 | 2020 | 3347 | 0.140 |
Why?
| | Herniorrhaphy | 1 | 2019 | 87 | 0.140 |
Why?
| | Soft Tissue Infections | 1 | 2019 | 42 | 0.140 |
Why?
| | Neck Injuries | 1 | 2019 | 22 | 0.140 |
Why?
| | Sensitivity and Specificity | 4 | 2026 | 1998 | 0.140 |
Why?
| | Wound Infection | 1 | 2019 | 60 | 0.140 |
Why?
| | Creatine Kinase | 1 | 2018 | 70 | 0.140 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1503 | 0.140 |
Why?
| | Angiography | 3 | 2025 | 206 | 0.140 |
Why?
| | Postoperative Care | 1 | 2020 | 301 | 0.140 |
Why?
| | Cause of Death | 3 | 2019 | 456 | 0.130 |
Why?
| | Survival Analysis | 4 | 2014 | 1378 | 0.130 |
Why?
| | Acute Disease | 3 | 2023 | 1038 | 0.130 |
Why?
| | Terminal Care | 1 | 2022 | 284 | 0.130 |
Why?
| | Traumatology | 1 | 2018 | 33 | 0.130 |
Why?
| | Organ Size | 1 | 2018 | 465 | 0.130 |
Why?
| | Insurance Coverage | 1 | 2019 | 248 | 0.130 |
Why?
| | Physical Examination | 1 | 2019 | 237 | 0.130 |
Why?
| | Point-of-Care Testing | 1 | 2017 | 36 | 0.130 |
Why?
| | Endosonography | 1 | 2019 | 160 | 0.130 |
Why?
| | Bronchoalveolar Lavage | 2 | 2015 | 90 | 0.130 |
Why?
| | Mothers | 1 | 2023 | 772 | 0.120 |
Why?
| | Health Care Costs | 1 | 2020 | 423 | 0.120 |
Why?
| | Chi-Square Distribution | 4 | 2012 | 517 | 0.120 |
Why?
| | Renal Dialysis | 1 | 2021 | 461 | 0.120 |
Why?
| | Lactic Acid | 1 | 2018 | 295 | 0.120 |
Why?
| | Drug Administration Schedule | 2 | 2020 | 790 | 0.120 |
Why?
| | Mass Screening | 1 | 2025 | 1307 | 0.120 |
Why?
| | Confidence Intervals | 2 | 2014 | 329 | 0.120 |
Why?
| | Jejunostomy | 1 | 2015 | 13 | 0.110 |
Why?
| | Vascular System Injuries | 1 | 2016 | 79 | 0.110 |
Why?
| | Respiratory Function Tests | 1 | 2017 | 543 | 0.110 |
Why?
| | Child | 10 | 2026 | 22693 | 0.110 |
Why?
| | Common Bile Duct | 2 | 2023 | 14 | 0.110 |
Why?
| | Monitoring, Physiologic | 3 | 2019 | 279 | 0.110 |
Why?
| | Depression | 1 | 2025 | 1575 | 0.110 |
Why?
| | Spinal Fractures | 1 | 2016 | 81 | 0.110 |
Why?
| | Rehydration Solutions | 1 | 2014 | 9 | 0.110 |
Why?
| | Isotonic Solutions | 1 | 2014 | 43 | 0.110 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 102 | 0.110 |
Why?
| | Erythrocyte Indices | 1 | 2014 | 33 | 0.100 |
Why?
| | Pain | 1 | 2020 | 790 | 0.100 |
Why?
| | Odds Ratio | 2 | 2014 | 1077 | 0.100 |
Why?
| | Decision Making | 1 | 2022 | 993 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 219 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 874 | 0.100 |
Why?
| | Hospitals, University | 1 | 2014 | 178 | 0.100 |
Why?
| | Watchful Waiting | 2 | 2024 | 90 | 0.100 |
Why?
| | Athletic Injuries | 1 | 2020 | 575 | 0.100 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2013 | 26 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 907 | 0.100 |
Why?
| | Ultrasonography | 2 | 2023 | 788 | 0.100 |
Why?
| | Antibiotic Prophylaxis | 2 | 2019 | 140 | 0.100 |
Why?
| | Rhabdomyolysis | 1 | 2013 | 24 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 253 | 0.090 |
Why?
| | Statistics, Nonparametric | 4 | 2019 | 426 | 0.090 |
Why?
| | Syndrome | 1 | 2013 | 380 | 0.090 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.090 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 432 | 0.090 |
Why?
| | Stents | 1 | 2016 | 554 | 0.090 |
Why?
| | Nitrogen | 1 | 2012 | 125 | 0.090 |
Why?
| | Wounds, Stab | 2 | 2008 | 12 | 0.080 |
Why?
| | Dietary Proteins | 1 | 2012 | 135 | 0.080 |
Why?
| | Multiple Trauma | 1 | 2012 | 118 | 0.080 |
Why?
| | Parenteral Nutrition | 2 | 2026 | 102 | 0.080 |
Why?
| | Rural Health Services | 1 | 2012 | 139 | 0.080 |
Why?
| | Propensity Score | 2 | 2025 | 376 | 0.080 |
Why?
| | Operative Time | 2 | 2023 | 195 | 0.080 |
Why?
| | Preoperative Care | 2 | 2012 | 396 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2012 | 1298 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 1 | 2013 | 358 | 0.080 |
Why?
| | Critical Pathways | 2 | 2009 | 104 | 0.080 |
Why?
| | Tidal Volume | 2 | 2022 | 108 | 0.080 |
Why?
| | Sex Factors | 4 | 2020 | 2107 | 0.080 |
Why?
| | Digital Rectal Examination | 1 | 2009 | 10 | 0.080 |
Why?
| | Sigmoidoscopy | 1 | 2009 | 14 | 0.080 |
Why?
| | Intestinal Fistula | 1 | 2009 | 17 | 0.080 |
Why?
| | Cerebral Angiography | 2 | 2023 | 121 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 478 | 0.070 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 234 | 0.070 |
Why?
| | Child, Preschool | 5 | 2026 | 11913 | 0.070 |
Why?
| | Polytetrafluoroethylene | 1 | 2009 | 24 | 0.070 |
Why?
| | Craniotomy | 1 | 2009 | 83 | 0.070 |
Why?
| | Coated Materials, Biocompatible | 1 | 2009 | 64 | 0.070 |
Why?
| | Splenic Rupture | 1 | 2008 | 5 | 0.070 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2008 | 29 | 0.070 |
Why?
| | Databases, Factual | 1 | 2014 | 1493 | 0.070 |
Why?
| | Rectum | 1 | 2009 | 180 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2008 | 54 | 0.070 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2008 | 77 | 0.070 |
Why?
| | Intracranial Pressure | 1 | 2008 | 64 | 0.070 |
Why?
| | Blood Vessel Prosthesis | 1 | 2009 | 133 | 0.070 |
Why?
| | Diaphragm | 1 | 2008 | 45 | 0.070 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 100 | 0.070 |
Why?
| | Diazepam | 1 | 2008 | 32 | 0.070 |
Why?
| | Wisconsin | 2 | 2022 | 102 | 0.070 |
Why?
| | Central Nervous System Depressants | 1 | 2008 | 83 | 0.060 |
Why?
| | Prevalence | 2 | 2025 | 2861 | 0.060 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 229 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1331 | 0.060 |
Why?
| | Nutrition Assessment | 1 | 2026 | 90 | 0.060 |
Why?
| | Exsanguination | 2 | 2019 | 18 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2008 | 185 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 223 | 0.060 |
Why?
| | Colostomy | 1 | 2025 | 28 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 866 | 0.050 |
Why?
| | Pancreas | 1 | 2007 | 343 | 0.050 |
Why?
| | Calcium | 1 | 2011 | 1181 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3926 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2009 | 397 | 0.050 |
Why?
| | Infant | 3 | 2026 | 10114 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 640 | 0.050 |
Why?
| | Hemoglobins | 1 | 2006 | 384 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2024 | 49 | 0.050 |
Why?
| | Anastomotic Leak | 1 | 2023 | 46 | 0.050 |
Why?
| | Ethanol | 1 | 2008 | 630 | 0.050 |
Why?
| | Postoperative Hemorrhage | 1 | 2024 | 106 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 46 | 0.050 |
Why?
| | Educational Measurement | 1 | 2026 | 331 | 0.050 |
Why?
| | Fracture Fixation | 1 | 2023 | 82 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6073 | 0.040 |
Why?
| | Morbidity | 1 | 2023 | 319 | 0.040 |
Why?
| | Vital Signs | 1 | 2022 | 39 | 0.040 |
Why?
| | Global Burden of Disease | 1 | 2022 | 25 | 0.040 |
Why?
| | Computed Tomography Angiography | 1 | 2023 | 151 | 0.040 |
Why?
| | Mesentery | 1 | 2021 | 44 | 0.040 |
Why?
| | Energy Intake | 2 | 2015 | 507 | 0.040 |
Why?
| | Bronchoscopy | 2 | 2015 | 227 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2022 | 142 | 0.040 |
Why?
| | Factor Xa | 1 | 2021 | 36 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 493 | 0.040 |
Why?
| | Shock | 1 | 2022 | 101 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 225 | 0.040 |
Why?
| | Alcoholism | 1 | 2008 | 830 | 0.040 |
Why?
| | Chemoprevention | 1 | 2020 | 91 | 0.040 |
Why?
| | Thoracotomy | 1 | 2020 | 87 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 351 | 0.040 |
Why?
| | Blood Coagulation Factors | 1 | 2021 | 71 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2019 | 80 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2329 | 0.040 |
Why?
| | Drainage | 1 | 2020 | 187 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1498 | 0.040 |
Why?
| | Fasciitis | 1 | 2019 | 11 | 0.040 |
Why?
| | Bilirubin | 1 | 2019 | 101 | 0.040 |
Why?
| | Lower Extremity | 1 | 2023 | 453 | 0.040 |
Why?
| | Cellulitis | 1 | 2019 | 55 | 0.040 |
Why?
| | Southwestern United States | 1 | 2019 | 93 | 0.040 |
Why?
| | Curriculum | 1 | 2026 | 1079 | 0.030 |
Why?
| | Neck Pain | 1 | 2019 | 35 | 0.030 |
Why?
| | Abscess | 1 | 2019 | 77 | 0.030 |
Why?
| | Aspirin | 1 | 2022 | 405 | 0.030 |
Why?
| | Staphylococcus epidermidis | 2 | 2009 | 80 | 0.030 |
Why?
| | Necrosis | 1 | 2019 | 243 | 0.030 |
Why?
| | Observer Variation | 1 | 2019 | 356 | 0.030 |
Why?
| | Needs Assessment | 1 | 2021 | 404 | 0.030 |
Why?
| | Reference Values | 1 | 2019 | 796 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1361 | 0.030 |
Why?
| | Clinical Competence | 1 | 2026 | 1272 | 0.030 |
Why?
| | Brachiocephalic Trunk | 1 | 2016 | 11 | 0.030 |
Why?
| | Axillary Artery | 1 | 2016 | 14 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 526 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 970 | 0.030 |
Why?
| | Canada | 1 | 2018 | 432 | 0.030 |
Why?
| | Ligation | 1 | 2016 | 88 | 0.030 |
Why?
| | Subclavian Artery | 1 | 2016 | 28 | 0.030 |
Why?
| | Angiography, Digital Subtraction | 1 | 2016 | 51 | 0.030 |
Why?
| | Carotid Artery Injuries | 1 | 2016 | 39 | 0.030 |
Why?
| | Pain Management | 1 | 2020 | 421 | 0.030 |
Why?
| | Orthotic Devices | 1 | 2016 | 26 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2016 | 56 | 0.030 |
Why?
| | Leukocytosis | 1 | 2015 | 31 | 0.030 |
Why?
| | False Negative Reactions | 1 | 2015 | 61 | 0.030 |
Why?
| | Leukopenia | 1 | 2015 | 33 | 0.030 |
Why?
| | Acid-Base Imbalance | 1 | 2014 | 3 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 90 | 0.030 |
Why?
| | Pneumonia | 1 | 2020 | 635 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 992 | 0.030 |
Why?
| | Erythrocyte Count | 1 | 2012 | 20 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2012 | 78 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2012 | 157 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 1135 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2991 | 0.020 |
Why?
| | Sigmoidoscopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 340 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 642 | 0.020 |
Why?
| | Superinfection | 1 | 2009 | 5 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2219 | 0.020 |
Why?
| | Adhesives | 1 | 2009 | 15 | 0.020 |
Why?
| | Aminoglycosides | 1 | 2009 | 29 | 0.020 |
Why?
| | Minocycline | 1 | 2009 | 23 | 0.020 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2008 | 5 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2008 | 6 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 193 | 0.020 |
Why?
| | Rifampin | 1 | 2009 | 80 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6460 | 0.020 |
Why?
| | Fasciotomy | 1 | 2008 | 24 | 0.020 |
Why?
| | Abdominal Wall | 1 | 2008 | 25 | 0.020 |
Why?
| | Hyperplasia | 1 | 2009 | 164 | 0.020 |
Why?
| | Decompression, Surgical | 1 | 2009 | 115 | 0.020 |
Why?
| | Methacrylates | 1 | 2009 | 119 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2008 | 80 | 0.020 |
Why?
| | Compartment Syndromes | 1 | 2008 | 36 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4340 | 0.020 |
Why?
| | Probability | 1 | 2008 | 309 | 0.020 |
Why?
| | Cost Savings | 1 | 2007 | 87 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2458 | 0.020 |
Why?
| | Swine | 1 | 2009 | 821 | 0.010 |
Why?
| | ROC Curve | 1 | 2008 | 617 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1036 | 0.010 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 298 | 0.010 |
Why?
| | Staphylococcus aureus | 1 | 2009 | 459 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1888 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4580 | 0.010 |
Why?
| | Animals | 1 | 2009 | 38107 | 0.000 |
Why?
|
|
Schroeppel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|